OKYO Pharma Ltd ADR

Company Profile

OKYO Pharma Ltd ADR had its IPO on 2022-05-17 under the ticker symbol OKYO.

The company operates in the Healthcare sector and Biotechnology industry. OKYO Pharma Ltd ADR has a staff strength of 8 employees.

Stock update

Shares of OKYO Pharma Ltd ADR opened at $1.88 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.88 - $2, and closed at $1.93.

This is a +0.52% increase from the previous day's closing price.

A total volume of 54,835 shares were traded at the close of the day’s session.

In the last one week, shares of OKYO Pharma Ltd ADR have slipped by -3.02%.

OKYO Pharma Ltd ADR's Key Ratios

OKYO Pharma Ltd ADR has a market cap of $50.85 million, indicating a price to book ratio of 12.9133 and a price to sales ratio of 0.

In the last 12-months OKYO Pharma Ltd ADR’s revenue was $0 with a gross profit of $-3599629 and an EBITDA of $-13183403. The EBITDA ratio measures OKYO Pharma Ltd ADR's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, OKYO Pharma Ltd ADR’s operating margin was 0% while its return on assets stood at -173.43% with a return of equity of -2968.51%.

In Q1, OKYO Pharma Ltd ADR’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

OKYO Pharma Ltd ADR’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.54 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into OKYO Pharma Ltd ADR’s profitability.

OKYO Pharma Ltd ADR stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -7.0052. Its price to sales ratio in the trailing 12-months stood at 0.

OKYO Pharma Ltd ADR stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$5.20 million

Total Liabilities

$7.26 million

Operating Cash Flow

$0

Capital Expenditure

$317.64

Dividend Payout Ratio

0%

OKYO Pharma Ltd ADR ended 2024 with $5.20 million in total assets and $0 in total liabilities. Its intangible assets were valued at $5.20 million while shareholder equity stood at $-2053237.00.

OKYO Pharma Ltd ADR ended 2024 with $0 in deferred long-term liabilities, $7.26 million in other current liabilities, 131385892.00 in common stock, $-125697719.00 in retained earnings and $0 in goodwill. Its cash balance stood at $4.05 million and cash and short-term investments were $4.05 million. The company’s total short-term debt was $2,215,111 while long-term debt stood at $0.

OKYO Pharma Ltd ADR’s total current assets stands at $5.20 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $980075.00 compared to accounts payable of $2.39 million and inventory worth $0.

In 2024, OKYO Pharma Ltd ADR's operating cash flow was $0 while its capital expenditure stood at $317.64.

Comparatively, OKYO Pharma Ltd ADR paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.93

52-Week High

$3.74

52-Week Low

$0.92

Analyst Target Price

$

OKYO Pharma Ltd ADR stock is currently trading at $1.93 per share. It touched a 52-week high of $3.74 and a 52-week low of $3.74. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $1.62 and 200-day moving average was $1.77 The short ratio stood at 0.47 indicating a short percent outstanding of 0%.

Around 4.9% of the company’s stock are held by insiders while 7.8% are held by institutions.